AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Levitasbio Completes Series C Financing

Nov 07, 2022•almost 3 years ago

Round Type

series c

Menlo ParkInformation Technology

Description

LevitasBio, Inc., www.levitasbio.com, a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.

Company Information

Company

LevitasBio

Location

1505 ADAMS DRIVE, #D

Menlo Park, California, United States

About

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular processing and characterization. Our disruptive levitation technology overcomes current technological limitations by providing a gentle, simple and label-free method of isolating specific cell populations. The LeviCell platform enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types, regardless of the starting cell number, viability, or sensitivity to processing.

Company News

(1 articles)

Tue, 07 Feb 2023 08:00:00 GMT

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits - Business Wire

FundzWatch™ Score

Medium Activity